rdf:type |
|
lifeskim:mentions |
umls-concept:C0019693,
umls-concept:C0023779,
umls-concept:C0030705,
umls-concept:C0082608,
umls-concept:C0085542,
umls-concept:C0087111,
umls-concept:C0376637,
umls-concept:C1704675,
umls-concept:C1707455,
umls-concept:C1963724,
umls-concept:C2003888
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-8-4
|
pubmed:abstractText |
Lipoprotein disorders in HIV-positive patients receiving highly active antiretroviral therapy (HAART) are becoming a major concern in HIV treatment, since there is growing evidence for an association between HAART-induced hyperlipidemia and increased cardiovascular risk. Yet relatively few data are available on the possible interactions of HAART and treatment with statins.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0300-8126
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-33
|
pubmed:dateRevised |
2006-9-18
|
pubmed:meshHeading |
pubmed-meshheading:15293079-Adult,
pubmed-meshheading:15293079-Anticholesteremic Agents,
pubmed-meshheading:15293079-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15293079-Fatty Acids, Monounsaturated,
pubmed-meshheading:15293079-Female,
pubmed-meshheading:15293079-HIV Infections,
pubmed-meshheading:15293079-HIV Protease Inhibitors,
pubmed-meshheading:15293079-Humans,
pubmed-meshheading:15293079-Hypercholesterolemia,
pubmed-meshheading:15293079-Indinavir,
pubmed-meshheading:15293079-Indoles,
pubmed-meshheading:15293079-Male,
pubmed-meshheading:15293079-Middle Aged,
pubmed-meshheading:15293079-Pravastatin,
pubmed-meshheading:15293079-Prospective Studies,
pubmed-meshheading:15293079-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
|
pubmed:affiliation |
Division of Infectious Diseases, Dept. of Internal Medicine, University of Würzburg, Josef-Schneider-Str. 2, D-97080 Würzburg, Germany. benesic_a@klinik.uni-wuerzburg.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|